Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)
AssigneeBreath Therapeutics GmbH
InventorsAldo Iacono, Oliver Denk, Gerhard Boerner
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition comprising cyclosporine A (CsA) for use in the prevention of bronchiolitis obliterans syndrome (BOS) in a double lung transplanted patient, or for the treatment of BOS or for the prevention or delay of the progression of BOS in a double lung transplanted patient being diagnosed with BOS, wherein the composition is administered to said patient by inhalation of said composition in aerosolized form comprising a therapeutically effective dose of cyclo-sporine A.
Claims27
A method for treating bronchiolitis obliterans syndrome (BOS) in a double lung transplanted patient, or for delaying the onset or progression of BOS in a double lung transplanted patient being diagnosed with BOS, the method comprising administering to said patient by inhalation a composition comprising liposomal cyclosporine A (L-CsA) in aerosolized form comprising a therapeutically effective dose of cyclosporine A.
Dependencies are inferred from the claim text.